COVID-19 research activity at RBFT
During the COVID-19 outbreak, the RBFT have taken part in a multitude of research studies to aid in finding best evidence based treatment for our patients as well as various surveys aimed at staff to provide data to researchers measuring the impact of the COVID-19 outbreak on health workers.
Taking part in this research at the Trust, means that we're aiding national public health research, and actively doing our bit to ensure we find a safe and effective treatment for COVID-19.
National Urgent Public Health studies the RBFT are taking part in currently:
REMAP-CAP - REMAP-CAP uses a novel and innovative adaptive trial design to evaluate a number of treatment options simultaneously and efficiently. This design is able to adapt in the event of pandemics, and increases the likelihood that patients will receive the treatment that is most likely to be effective for them.
RECOVERY - Researchers are assessing whether a number of potential therapeutic treatments can improve health outcomes for patients hospitalised with suspected or confirmed COVID-19.
PRIEST - The PRIEST study will optimise the triage of patients using emergency care with suspected respiratory infections and identify the most accurate triage method for predicting severe illness.
ISARIC - An observational study collecting samples and data from patients which will help understand the characteristics of the virus, how it replicates, and factors affecting underlying individual susceptibility
GeNOmiccs - The GenOMICC study will identify the specific genes that cause some people to be susceptible to specific infections and consequences of severe injury.
with further studies of national interest in the initial set-up phase or already open and running at site.
Research & Development
0118 322 8140